Advertisement
Journal Home
Search for

Volume 84, Issue 2, Pages 193-198 (March 2010)


View previous. 11 of 15 View next.

Effect of vascular endothelial growth factor and interleukin-1β on apoptosis in endometrial cell cultures from patients with endometriosis and controls

Mariela BilotasaCorresponding Author Informationemail address, Gabriela Meresmana, Ricardo Buquetb, Carlos Sueldoc, Rosa Inés Barañaoa

Received 17 March 2009; received in revised form 18 November 2009; accepted 1 December 2009. published online 14 January 2010.

Abstract 

The aim of this study was to evaluate the effect of vascular endothelial growth factor (VEGF) and interleukin-1β (IL-1β) on apoptosis induced by leuprolide acetate (LA) in endometrial epithelial cell cultures from patients with endometriosis. Primary endometrial epithelial cell cultures were obtained from uterine endometrial biopsies of patients with endometriosis and control women. Endometrial epithelial cells were incubated with LA; a combination of LA and VEGF; a combination of LA and IL-1β; or in basal conditions. LA was added 3h prior to addition of VEGF and IL-1β. After stimulation, the percentage of apoptotic cells was evaluated by the acridine orange–ethidium bromide technique and Bax expression was assessed by western blot. Treatment with LA enhanced the percentage of apoptotic cells in endometrial epithelial cells from subjects with endometriosis and control subjects. Addition of either VEGF or IL-1β after exposure to LA restored the percentage of apoptotic cells to basal levels. Moreover, treatment with LA increased Bax expression in endometrial epithelial cells from patients with endometriosis. This effect was reverted by the addition of either VEGF or IL-1β. Our results show that VEGF and IL-1β reduce apoptosis and decrease Bax expression in endometrial epithelial cells from patients with endometriosis. This study suggests that VEGF and IL-1β may protect endometriotic cells from undergoing apoptosis in addition to exerting their pro-angiogenic role.

a Instituto de Biología y Medicina Experimental (IBYME), Vuelta de Obligado 2490, C1428ADN Buenos Aires, Argentina

b Departamento de Ginecología, Hospital de Clínicas “José de San Martín”, C1120AAF Buenos Aires, Argentina

c Centro de Estudios en Ginecología y Reproducción (CEGyR), C1055ABB Buenos Aires, Argentina

Corresponding Author InformationCorresponding author. Tel.: +54 11 47832869; fax: +54 11 47842564.

PII: S0165-0378(10)00007-0

doi:10.1016/j.jri.2009.12.002


View previous. 11 of 15 View next.

Advertisement